CANB Stock Overview
Can B Corp., a health and wellness company, develops, manufactures, and sells hemp derived products in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Can B Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.035 |
| 52 Week High | US$0.89 |
| 52 Week Low | US$0.012 |
| Beta | 1.59 |
| 1 Month Change | -26.32% |
| 3 Month Change | 29.63% |
| 1 Year Change | -94.57% |
| 3 Year Change | -99.52% |
| 5 Year Change | -99.99% |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| CANB | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 1.4% | 0.08% | 1.2% |
| 1Y | -94.6% | 13.2% | 24.9% |
Return vs Industry: CANB underperformed the US Pharmaceuticals industry which returned 13.9% over the past year.
Return vs Market: CANB underperformed the US Market which returned 24.7% over the past year.
Price Volatility
| CANB volatility | |
|---|---|
| CANB Average Weekly Movement | 33.9% |
| Pharmaceuticals Industry Average Movement | 9.8% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: CANB's share price has been volatile over the past 3 months.
Volatility Over Time: CANB's weekly volatility has decreased from 43% to 34% over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | 12 | Marco Alfonsi | canbcorp.com |
Can B Corp., a health and wellness company, develops, manufactures, and sells hemp derived products in the United States. The company provides CBD products derived from hemp, including oils, creams, moisturizers, isolate, gel caps, spa products, concentrates, and lifestyle products. It sells its products under the Canbiola, Nu Wellness, Seven Chakras, and Pure Leaf Oil brands through medical professionals, website, and vending machines.
Can B Corp. Fundamentals Summary
| CANB fundamental statistics | |
|---|---|
| Market cap | US$1.83m |
| Earnings (TTM) | -US$9.74m |
| Revenue (TTM) | US$2.16m |
0.8x
P/S Ratio-0.2x
P/E RatioIs CANB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CANB income statement (TTM) | |
|---|---|
| Revenue | US$2.16m |
| Cost of Revenue | US$1.80m |
| Gross Profit | US$358.70k |
| Other Expenses | US$10.10m |
| Earnings | -US$9.74m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.19 |
| Gross Margin | 16.64% |
| Net Profit Margin | -451.70% |
| Debt/Equity Ratio | -890.9% |
How did CANB perform over the long term?
See historical performance and comparison